TCGA datasets showed that PRMT5 levels are significantly higher in glioma than in normal brain tissues, and high PRMT5 levels predict poor prognosis in glioma patients (Figure S4B,C, Supporting Information). Here, PRMT5 is linked to central nervous system cancer.